In another promising development in the quest to end the pandemic, a COVID-19 vaccine developed by Oxford-AstraZeneca has prevented a majority of people from getting the disease in a large trial. Watch the video to find out how a dosing error turned into a lucky punch for AstraZeneca and Oxford.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
